MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

MDT

96.83

-2.02%↓

139.62

-3.71%↓

VEEV

222.3

+1.47%↑

HQY

85.02

-2.1%↓

NEOG

9.24

-2.22%↓

Kodu・Aktsiate loetelu・NeoGenomics Inc

NeoGenomics Inc

Suletud

12.76 -0.39

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

12.71

Max

12.86

Põhinäitajad
By Trading Economics
Sissetulek	18M -27M
Müük	6.5M 188M
Kasumimarginaal	-14.446
Töötajad	2,200
EBITDA	38M -10M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+9.46% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	17. veebr 2026

Turustatistika
By TradingEconomics
Turukapital	304M 1.6B
Eelmine avamishind	13.15
Eelmine sulgemishind	12.76

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

7.7 / 10.27 Toetus ja vastupanu

NeoGenomics Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

16. jaan 2026, 16:01 UTC

Suurimad hinnamuutused turgudel

Omandamised, ülevõtmised, äriostud

Riot Platforms Shares Rise After Texas Land Buy, Data Center Lease

15. jaan 2026, 17:51 UTC

Suurimad hinnamuutused turgudel

Galaxy Digital Climbs on Texas Data-Center Expansion Approval, Tokenized CLO Issuance

6. jaan 2026, 17:41 UTC

Suurimad hinnamuutused turgudel

Blink Charging Shares Rise as EV Chargers Begin Accepting Cryptocurrency

5. jaan 2026, 16:18 UTC

Suurimad hinnamuutused turgudel

DeFi Development Shares Rise After Partnership With Hylo

5. jaan 2026, 14:17 UTC

Uudisväärsed sündmused

Bitcoin Gains as Traders Speculate Over Impact of U.S. Actions in Venezuela

16. jaan 2026, 13:35 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

16. jaan 2026, 13:35 UTC

Market Talk

Demand For Potential Digital Euro Will Determine Its Impact -- Market Talk

16. jaan 2026, 08:08 UTC

Market Talk

Bitcoin Falls as Traders Take Profits -- Market Talk

15. jaan 2026, 08:23 UTC

Market Talk

Bitcoin Eases Following Falls in Tech Stocks -- Market Talk

14. jaan 2026, 08:19 UTC

Market Talk

Bitcoin Rises on Optimism Over Crypto Regulation, Rate Cut Bets -- Market Talk

14. jaan 2026, 08:19 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

14. jaan 2026, 06:00 UTC

Tulu

The First Crypto IPO of 2026 Is Coming Soon. It's a Risky Bet. -- Barrons.com

14. jaan 2026, 05:30 UTC

Market Talk

Bitcoin Climbs After Decisive Range Breakout, Technical Analysis Shows -- Market Talk

13. jaan 2026, 13:09 UTC

Market Talk

Ethereum Could Outperform Bitcoin as Its Prospects Improve -- Market Talk

13. jaan 2026, 13:02 UTC

Omandamised, ülevõtmised, äriostud

Bitcoin Depot Acquires the Assets of Regional Bitcoin ATM Operator, Instant Coin Bank

13. jaan 2026, 11:05 UTC

Market Talk

Outflows From Crypto Funds Hold Back Recovery -- Market Talk

13. jaan 2026, 08:16 UTC

Market Talk

Bitcoin Edges Higher After U.S. Stocks Rise -- Market Talk

12. jaan 2026, 17:51 UTC

Market Talk

Stablecoin Adoption Seen as Gradual Threat to Traditional Fintech -- Market Talk

12. jaan 2026, 16:01 UTC

Market Talk

Bitcoin Seen as Alternative Amid Fed Independence Worries -- Market Talk

12. jaan 2026, 13:05 UTC

Omandamised, ülevõtmised, äriostud

Bakkt Holdings: To Continue to Trade on NY Stk Exchange Under the Ticker Symbol BKKT >BKKT

12. jaan 2026, 13:05 UTC

Omandamised, ülevõtmised, äriostud

Bakkt Holdings: Intend to Change Its Corporate Name to Bakkt Inc. >BKKT

12. jaan 2026, 13:04 UTC

Omandamised, ülevõtmised, äriostud

Bakkt Holdings Intercontinental Exchange, Which Beneficially Owns About 31% of Bakkt's Outstanding Class A Common Stk, Has Agreed to Vote Such Shrs in Favor of the Transaction >BKKT

12. jaan 2026, 09:38 UTC

Market Talk

Bitcoin Trims Gains as Fed Independence Concerns Mount -- Market Talk

9. jaan 2026, 08:00 UTC

Market Talk

Bitcoin Falls Ahead of U.S. Jobs Data -- Market Talk

8. jaan 2026, 07:59 UTC

Market Talk

Bitcoin Falls as Traders Take Profits After Recent Gains -- Market Talk

6. jaan 2026, 12:26 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. jaan 2026, 12:26 UTC

Market Talk

Geopolitical Tensions Could Benefit Bitcoin -- Market Talk

6. jaan 2026, 10:22 UTC

Market Talk

Bitcoin's Recent Recovery Could Be Short-Lived -- Market Talk

6. jaan 2026, 08:08 UTC

Market Talk

Bitcoin Eases But Stays Above $90K After Venezuela News -- Market Talk

5. jaan 2026, 17:08 UTC

Tulu

Strategy Records $17.44 Billion Unrealized Loss in Fourth Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

NeoGenomics Inc Prognoos

Hinnasiht

By TipRanks

9.46% tõus

12 kuu keskmine prognoos

Keskmine 14 USD 9.46%

Kõrge 16 USD

Madal 12 USD

Põhineb 11 Wall Streeti analüütiku instrumendi NeoGenomics Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

11 ratings

Osta

Hoia

Müü

Põhineb 11 analüütiku instrumendi NeoGenomics Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

7.7 / 10.27Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest NeoGenomics Inc

NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. It operates through Clinical Services and Advanced Diagnostics segments. The company offers testing services to hospitals, academic centers, pathologists, oncologists, clinicians, pharmaceutical companies, and clinical laboratories. It also provides cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; and immunohistochemistry and digital imaging testing services to localize cellular proteins in tissue section, as well as to allow clients to visualize scanned slides, and perform quantitative analysis for various stains. In addition, the company also provides molecular testing services, which focus on the analysis of DNA and/or RNA, and the structure and function of genes at the molecular level; morphologic analysis, which is the process of analyzing cells under the microscope by a pathologist for the purpose of diagnosis; and testing services in support of its pharmaceutical clients' oncology programs covering discovery and commercialization. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.